Symptoms include shakiness, sweating, dizziness, and confusion
As other members of the SLC22 family, OCTN2 can mediate cellular uptake of oxaliplatin and other chemotherapeutic agents (Jong et al., 2011
Some practitioners use subcutaneous injections of 200 to 300 mcg once or twice daily, injected into abdominal subcutaneous tissue near the area of concern
Issued on 2 April 2026, following an inspection of the company's Livonia facility in October 2025, the letter identifies multiple violations of Current Good Manufacturing Practice (cGMP) regulations under 21 CFR parts 210 and 211
Does Aetna Cover Zepbound for Weight Loss
MT-1 was originally developed as a potential therapeutic agent for conditions like erythropoietic protoporphyria (EPP) and other photosensitivity disorders, where increased melanin production could reduce UV-induced damage